These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 25261534)

  • 1. Interaction of risk factors, comorbidities, and comedications with ischemia/reperfusion injury and cardioprotection by preconditioning, postconditioning, and remote conditioning.
    Ferdinandy P; Hausenloy DJ; Heusch G; Baxter GF; Schulz R
    Pharmacol Rev; 2014 Oct; 66(4):1142-74. PubMed ID: 25261534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning.
    Ferdinandy P; Andreadou I; Baxter GF; Bøtker HE; Davidson SM; Dobrev D; Gersh BJ; Heusch G; Lecour S; Ruiz-Meana M; Zuurbier CJ; Hausenloy DJ; Schulz R
    Pharmacol Rev; 2023 Jan; 75(1):159-216. PubMed ID: 36753049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
    Ferdinandy P; Schulz R; Baxter GF
    Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning.
    Heusch G
    Circ Res; 2015 Feb; 116(4):674-99. PubMed ID: 25677517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical Issues for the Translation of Cardioprotection.
    Heusch G
    Circ Res; 2017 Apr; 120(9):1477-1486. PubMed ID: 28450365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What is Wrong With Cardiac Conditioning? We May be Shooting at Moving Targets.
    Iliodromitis EK; Cohen MV; Dagres N; Andreadou I; Kremastinos DT; Downey JM
    J Cardiovasc Pharmacol Ther; 2015 Jul; 20(4):357-69. PubMed ID: 25627214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of gasotransmitters NO, H2S and CO in myocardial ischaemia/reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning.
    Andreadou I; Iliodromitis EK; Rassaf T; Schulz R; Papapetropoulos A; Ferdinandy P
    Br J Pharmacol; 2015 Mar; 172(6):1587-606. PubMed ID: 24923364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time to Give Up on Cardioprotection? A Critical Appraisal of Clinical Studies on Ischemic Pre-, Post-, and Remote Conditioning.
    Heusch G; Rassaf T
    Circ Res; 2016 Aug; 119(5):676-95. PubMed ID: 27539973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology of myocardial reperfusion injury: preconditioning, postconditioning, and translational aspects of protective measures.
    Sanada S; Komuro I; Kitakaze M
    Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H1723-41. PubMed ID: 21856909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous Cardioprotective Agents: Role in Pre and Postconditioning.
    Penna C; Granata R; Tocchetti CG; Gallo MP; Alloatti G; Pagliaro P
    Curr Drug Targets; 2015; 16(8):843-67. PubMed ID: 25751010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perconditioning and postconditioning: current knowledge, knowledge gaps, barriers to adoption, and future directions.
    Vinten-Johansen J; Shi W
    J Cardiovasc Pharmacol Ther; 2011; 16(3-4):260-6. PubMed ID: 21821526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signaling mediators modulated by cardioprotective interventions in healthy and diabetic myocardium with ischaemia-reperfusion injury.
    Saeid F; Aniseh J; Reza B; Manouchehr VS
    Eur J Prev Cardiol; 2018 Sep; 25(14):1463-1481. PubMed ID: 29442529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional Genomics of Cardioprotection by Ischemic Conditioning and the Influence of Comorbid Conditions: Implications in Target Identification.
    Varga ZV; Giricz Z; Bencsik P; Madonna R; Gyongyosi M; Schulz R; Mayr M; Thum T; Puskas LG; Ferdinandy P
    Curr Drug Targets; 2015; 16(8):904-11. PubMed ID: 25915487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic therapy that simulates conditioning for cardiac ischemic/reperfusion injury.
    Sivaraman V; Yellon DM
    J Cardiovasc Pharmacol Ther; 2014 Jan; 19(1):83-96. PubMed ID: 24038018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical translation of myocardial conditioning.
    Bøtker HE; Lassen TR; Jespersen NR
    Am J Physiol Heart Circ Physiol; 2018 Jun; 314(6):H1225-H1252. PubMed ID: 29498531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protecting the heart from ischemia/reperfusion injury: an update on remote ischemic preconditioning and postconditioning.
    Donato M; Evelson P; Gelpi RJ
    Curr Opin Cardiol; 2017 Nov; 32(6):784-790. PubMed ID: 28902715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Can any heart be preconditioned? Influence of aging and comorbidities on cardioprotection].
    Bilińska M
    Kardiol Pol; 2011; 69 Suppl 3():85-8. PubMed ID: 22125209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging role of non-coding RNAs and extracellular vesicles in cardioprotection by remote ischemic conditioning of the heart.
    Bartekova M; Jelemensky M; Dhalla NS
    Rev Cardiovasc Med; 2019 Jun; 20(2):59-71. PubMed ID: 31344998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Realizing the clinical potential of ischemic preconditioning and postconditioning.
    Yellon DM; Hausenloy DJ
    Nat Clin Pract Cardiovasc Med; 2005 Nov; 2(11):568-75. PubMed ID: 16258568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endless Journey of Adenosine Signaling in Cardioprotective Mechanism of Conditioning Techniques: Clinical Evidence.
    Kumar K; Singh N; Yadav HN; Maslov L; Jaggi AS
    Curr Cardiol Rev; 2023; 19(6):56-71. PubMed ID: 37309766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.